{{Rsnum
|rsid=2952155
|Gene=ERBB2
|Chromosome=17
|position=39705465
|Orientation=plus
|GMAF=0.3664
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ERBB2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.5 | 36.9 | 1.5
| HCB | 28.9 | 40.0 | 31.1
| JPT | 36.4 | 47.7 | 15.9
| YRI | 34.9 | 42.9 | 22.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 28.9 | 40.0 | 31.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2952155
|Name_s=
|Gene_s=ERBB2
|Feature=
|Evidence=PubMed ID:15743501
|Annotation=Risk or phenotype-associated allele: none. Phenotype: Breast cancer risk. Study size: 2192 (1438 incident and 754 prevalent) cases and 2257 controls. Study population/ethnicity: British female breast cancer patients < 55 years of age (prevalent cases) recruited between 1 January 1991 and 30 June 1996, and < 70 years of age diagnosed from 1996 onwards (incident cases), and ethinic-matched European controls. Significance metric(s): p = 0.48 (non-significant). Type of association: GN; CO.
|Drugs=
|Drug Classes=
|Diseases=Breast Neoplasms
|Curation Level=Curated
|PharmGKB Accession ID=PA165290957
}}

{{PMID|17132159|OA=1
}} Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.

{{PMID|19240718|OA=1
}} Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2952155
|overall_frequency_n=86
|overall_frequency_d=126
|overall_frequency=0.68254
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=71
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}